# Release Readiness Report

## 2026-08-10 authoritative Tier 1 P1 closure — final verdict

**NO-GO.** Repository authority, provider call-ID collision handling, queue isolation, retry lifecycle, bounded recovery/operator retry, emergency claim truthfulness, and exact signed identity replay are internally accepted. The eligibility closure is rejected after the maximum two remediation cycles.

Remaining P1 blockers:

1. Stale `PROVIDER_IN_FLIGHT` eligibility executions have no production caller for the reconciliation scanner and are omitted from the clinic reconciliation list, so a post-claim crash can remain invisible indefinitely.
2. `confirmed_succeeded` returns `manual_evidence_pending` without durably persisting or auditing that state, reason, or staff work item.
3. Browser idempotency keys survive ambiguity only in memory; a reload/process loss can assign a new key to the same logical action.
4. The required normal full regression fails 1/1,946 assertions because the shared append-only evidence manifest does not include the new `EligibilityExecution` delete-protection entry.

P2 items: multi-instance recovery can duplicate bounded scan/Redis reads without a distributed lease; isolated test imports can leave meta-only Redis keys; no clinic-facing eligibility reconciliation UI or staff eligibility Playwright scenario exists. Actual emergency spoken-before-tool timing remains external provider evidence and is not claimed as verified.

`npm run check`, production build, zero-to-head migration, genuine 86→87 upgrade, drift, runtime role, full RLS, focused finance/booking/data/content, AI/queue suites, and the scoped desktop/mobile portal-insurance Playwright run pass. No release tag, push, deployment, Tier 2 execution, live provider transaction, or real PHI is authorized.

## 2026-08-10 Tier 1 wave — authoritative current verdict

**NO-GO.** This current working tree must not inherit the older GO verdict below.

Release blockers:

1. Repository authority is unresolved: the primary tree contains substantial uncommitted work, six previously reported dirty/unique worktrees no longer exist at their registered paths, and `codex/accepted-module-convergence` has extensive divergent history from the ledger-declared branch.
2. Eligibility provider calls and subsequent durable effects lack a tenant-scoped idempotent/atomic workflow boundary.
3. Persistent BullMQ queues are not scoped to a disposable database/environment; stale jobs crossed the Chrome test dataset boundary.
4. Autopilot recovery is serial and slow for 101 jobs, and `dispatch_failed` work has no authorized tenant retry path.
5. The single required end-wave disposable full regression failed its default timing gate: 106/109 files and 1,899/1,902 tests passed, while three tests timed out. Those 3 files passed 60/60 with a 30-second ceiling, so this is a performance/test-budget failure rather than an assertion failure.
6. `npm run check` fails on two lint errors in the pre-existing untracked `.playwright-no-server.config.ts`; Prisma validation and API typecheck pass, but the production build stage is not reached by the umbrella command.
7. Independent review found two further P1s: outbound call-ID collision can continue without durable binding, and BullMQ failure handling marks dispatch terminal before scheduled retry exhaustion.

Positive evidence includes successful zero-to-head Tier 1 generation, focused finance/core/worker/voice suites, restricted local infrastructure, corrected financial webhook behavior, real atomic staff-task execution, and corrected Chrome-observed branch/dashboard/scheduling behavior. Live calls were authorization-blocked; object storage and email lanes were setup-required. No real payment, claim, eligibility transaction, production data, or PHI was used.

The older report is retained below as historical evidence only and does not describe this tree.

Independent acceptance result: F1/F2/F4 REJECTED; F3/F5/F6 scoped PASS; F7/F8 narrow defect-level PASS. Overall REJECTED / NO-GO.

Date: 2026-07-30  
Scope: local repository and disposable local databases using synthetic data only.

This is the authoritative current checkpoint. Older dated entries in the evidence ledger are historical observations, not current defects.

## Three separate verdicts

| Decision | Current verdict | Basis |
|---|---|---|
| Internal engineering release candidate | GO | G1-G20 pass; logical attributed commits, committed-state verification, and the annotated local RC tag are complete |
| Supervised synthetic-data pilot | GO | Synthetic data only, accountable human supervision, rehearsed stop path, and no live external transactions |
| Production PHI or unattended autonomous receptionist | NO-GO | Live-provider, legal, clinical, privacy, security-operations, backup/restore, and organizational compliance evidence are external prerequisites |

No document in this repository is a HIPAA, SOC 2, or GDPR certification or legal opinion.

## Current engineering evidence

- Production artifact scanner passes source, configuration, Prisma, server, and built assets.
- The production dependency audit reports zero vulnerabilities at the configured high-severity gate; package signatures pass.
- The tenant and platform database planes use separate roles, clients, grants, and runtime context.
- The catalog contains 127 application tables: 119 protected and 8 explicit exemptions. All 119 protected tables have ENABLE and FORCE RLS, 522 policies are installed, and `app_rls` is non-superuser/non-BYPASSRLS and owns no protected table.
- Restricted-role behavioral coverage passes 962/962 assertions across all 119 protected tables, including same-tenant, cross-tenant, no-context, and pool-reuse behavior.
- The Prisma drift guard recognizes migration-owned objects and reports no unexpected destructive change; 120 composite tenant foreign keys remain protected.
- The current disposable clean/upgrade lifecycle passes all 69 migrations, deterministic seeding, tenant-integrity checks, and teardown.
- Two consecutive final-tree full regressions pass 78 files and 469/469 tests each.
- Real-backend Playwright passes 10/10 across desktop and Pixel 7 profiles, including the golden patient/staff journey and 93 role-route traversals over 32 unique staff routes.
- Independent security/RLS, clinical/operational, and QA/release challenges report zero known P0/P1/P2 after cross-review and receipt replay closure.
- The PILOT profile benchmark passes its local 750 ms/query regression budget; observed maxima were 18.90 ms patient search, 33.67 ms appointment calendar, 32.11 ms dashboard aggregate, 49.26 ms audit search, 9.39 ms receptionist events, 8.23 ms documents, 15.56 ms notifications, 15.80 ms pagination, and 2.73 ms platform overview. This is not a customer-capacity claim.

## Release gates

| Gate | Status | Evidence |
|---|---|---|
| G1-G2 demo/build artifacts | PASS | `npm run verify:no-production-demo-artifacts`; production build |
| G3 route/action certification | PASS | 32 unique staff routes / 93 role-route traversals plus patient, public, and platform journeys; 15 action-defect classes repaired or removed |
| G4-G5 database-plane separation and grants | PASS | platform-plane integration tests and `rls:verify` |
| G6 RLS catalog | PASS | current 69-migration result: 119/119 protected, 522 policies, forced/enabled 119 |
| G7-G8 drift and protected objects | PASS | drift guard; 120 migration-owned composite FKs protected |
| G9-G10 behavioral RLS/context | PASS | current 69-migration disposable result: 962/962 restricted-role assertions |
| G11 first inbound Retell | PASS locally | signed unique destination mapping; unknown/ambiguous input fails to manual review |
| G12 dependency remediation | PASS | production audit: zero vulnerabilities |
| G13-G14 synthetic profiles | PASS | deterministic FUNCTIONAL, PILOT, and EDGE profiles/scenario catalog |
| G15 browser E2E | PASS | 10/10 real-backend desktop/mobile golden and role-aware route/action journeys |
| G16 migration/seed/restore | PASS locally | disposable 69-migration clean/upgrade/seed/teardown lifecycle and prior isolated backup/restore drill |
| G17 repeated full regression | PASS | two consecutive final-tree runs: 78 files, 469/469 tests each |
| G18 zero internal P0/P1 | PASS | independent challenges report P0=0, P1=0; final receipt review also reports P2=0 |
| G19 independent acceptance | PASS | security/RLS, clinical/operational, and QA/release challenge reviews pass |
| G20 immutable local RC | PASS | logical attributed commits; committed-state release suite; clean status; annotated local tag `rc/pilot-convergence-2026-07-30` |

## Scope boundary

The product is an operational clinic-management system, not an EHR, diagnostic, prescribing, or autonomous clinical-decision system. No production deployment, database access, remote push, real PHI, call, message, appointment, eligibility check, claim, or payment was performed.
